Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revatio in cardiac surgery patients at risk of AKI
NCT02136329Phase 1Completed
- Sponsor
- University of Leicester
- Start
- Jun 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sildenafil in acute kidney injury (AKI), sponsored by University of Leicester. Primary endpoints: Area under the plasma concentration versus time curve at 48 hours and Plasma Concentration of Sildenafil at 48 hours. Started Jun 2013; status: completed.
02
Drugs
sildenafil
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02136329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02136329.